Hepatitis B virus capsid: localization of the putative immunodominant loop (residues 78 to 83) on the capsid surface, and implications for the distinction between c and e-antigens

Journal of Molecular Biology
J F ConwayA C Steven

Abstract

Hepatitis B virus capsid protein comprises a 149 residue "assembly" domain that polymerizes into icosahedral particles, and a 34 residue RNA-binding "protamine" domain. Recently, the capsid structure has been studied to resolutions below 10 A by cryo-electron microscopy, revealing much of its alpha-helical substructure and that it appears to have a novel fold for a capsid protein; however, the resolution is still too low for chain-tracing by conventional criteria. Aiming to establish a fiducial marker to aid in the process of chain-tracing, we have used cryo-microscopy to pinpoint the binding site of a monoclonal antibody that recognizes the peptide from residues 78 to 83. This epitope resides on the outer rim of the 30 A long spikes that protrude from the capsid shell. These spikes are four-helix bundles formed by the pairing of helix-turn-helix motifs from two subunits; by means of a tilting experiment, we have determined that this bundle is right-handed. Variants of the same protein present two clinically important and non-crossreactive antigens: core antigen (HBcAg), which appears early in infection as assembled capsids; and the sentinel e-antigen (HBeAg), a non-particulate form. Knowledge of the binding site of our anti-HB...Continue Reading

References

Dec 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·B L TrusA C Steven
Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·S SheriffD R Davies
Jan 1, 1989·Annual Review of Biochemistry·M G Rossmann, J E Johnson
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S R Presnell, F E Cohen
Jan 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·T S BakerM Bina
May 27, 1971·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R A Crowther
Nov 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·D M SegalD R Davies
Mar 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S StahlK Murray
Nov 1, 1993·Journal of Structural Biology·J F ConwayA C Steven
Sep 1, 1993·Trends in Microbiology·M Nassal, H Schaller
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·F P BooyA C Steven
Jan 1, 1995·Intervirology·M Seifer, D N Standring
Jan 1, 1995·Intervirology·P PumpensE Grens
Apr 1, 1997·Journal of Structural Biology·R Bringas
Jul 8, 1997·Proceedings of the National Academy of Sciences of the United States of America·B S Blumberg
Sep 2, 1997·Proceedings of the National Academy of Sciences of the United States of America·A ZlotnickP T Wingfield
Nov 14, 1997·Journal of Structural Biology·D M BelnapT S Baker
Jan 1, 1962·Cold Spring Harbor Symposia on Quantitative Biology·D L CASPAR, A KLUG

❮ Previous
Next ❯

Citations

Sep 21, 2007·Journal of Virology·Michael NassalJolanta Vorreiter
Dec 10, 1999·Journal of Virology·M KoschelV Bruss
Apr 23, 2002·Journal of Virology·Adam ZlotnickJennifer M Johnson
Mar 8, 2000·Microbiology and Molecular Biology Reviews : MMBR·C Seeger, W S Mason
May 1, 1999·Biological Chemistry·G BorisovaE Grens
Sep 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·D M BelnapA C Steven
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·J F ConwayA C Steven
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·P A KratzM Nassal
Mar 10, 2015·The Journal of Clinical Investigation·Jeanne H SchickliDavid R Milich
Aug 3, 2016·Annual Review of Virology·Balasubramanian Venkatakrishnan, Adam Zlotnick
Jul 8, 1999·Molecular Cell·S A WynneA G Leslie
Sep 25, 2007·International Journal of Medical Microbiology : IJMM·Michael NassalMarkus M Simon
Apr 10, 2014·Protein Science : a Publication of the Protein Society·Jessica Z BereszczakAlbert J R Heck
Oct 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David Milich, T Jake Liang
Sep 11, 2014·World Journal of Gastroenterology : WJG·Wen Siang Tan, Kok Lian Ho
Jan 2, 2001·The Journal of Biological Chemistry·G Beterams, M Nassal
Apr 23, 2008·Current Protocols in Protein Science·Alasdair Steven, David Belnap
Jan 5, 2007·World Journal of Gastroenterology : WJG·Jia-Yu Chen, Fan Li
Dec 25, 2017·Nanomedicine : Nanotechnology, Biology, and Medicine·Wenjun ShanXianzhong Zhang
Oct 9, 2007·Journal of Medicinal Chemistry·Kah Fai TangWen Siang Tan
Mar 13, 2001·Journal of Molecular Biology·E ThouveninE Hewat
May 18, 1999·Journal of Molecular Biology·M ValleJ L Carrascosa
Jul 3, 2021·Viruses·Marina Campos-ValdezLaura V Sánchez-Orozco

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

BK Virus Infection

BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Discover the latest research on BK virus infection here.